Reuters logo
BRIEF-Verona Pharma announces pricing of global offering, approval to list on NASDAQ
2017年4月27日 / 凌晨3点28分 / 5 个月前

BRIEF-Verona Pharma announces pricing of global offering, approval to list on NASDAQ

April 26 (Reuters) - Verona Pharma Plc

* Verona Pharma announces pricing of global offering and approval to list on the NASDAQ global market

* Pricing of its global offering comprising 5.7 million American Depositary Shares at a price of $13.50 per ADS

* Pricing of global offering also comprising 1.2 million ordinary shares at a price of £1.32 per ordinary share Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below